Asset Details
Do you wish to reserve the book?
Classification of endometrial carcinoma: more than two types
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Classification of endometrial carcinoma: more than two types
Do you wish to request the book?
Classification of endometrial carcinoma: more than two types
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Classification of endometrial carcinoma: more than two types
2014
Overview
Endometrial cancer is the most common gynaecological malignancy in Europe and North America. Traditional classification of endometrial carcinoma is based either on clinical and endocrine features (eg, types I and II) or on histopathological characteristics (eg, endometrioid, serous, or clear-cell adenocarcinoma). Subtypes defined by the different classification systems correlate to some extent, but there is substantial heterogeneity in biological, pathological, and molecular features within tumour types from both classification systems. In this Review we provide an overview of traditional and newer genomic classifications of endometrial cancer. We discuss how a classification system that incorporates genomic and histopathological features to define biologically and clinically relevant subsets of the disease would be useful. Such integrated classification might facilitate development of treatments tailored to specific disease subgroups and could potentially enable delivery of precision medicine to patients with endometrial cancer.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
Class I Phosphatidylinositol 3-Kinases
/ Endometrial Neoplasms - classification
/ Endometrial Neoplasms - genetics
/ Endometrial Neoplasms - pathology
/ Endometrial Neoplasms - therapy
/ Female
/ Hematology, Oncology, and Palliative Medicine
/ Humans
/ Mutation
/ Phosphatidylinositol 3-Kinases - genetics
/ Protein Phosphatase 2 - genetics
